MCF Advisors’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-2,913
| Closed | -$40K | – | 462 |
|
2020
Q2 | $40K | Hold |
2,913
| – | – | 0.01% | 241 |
|
2020
Q1 | $22K | Hold |
2,913
| – | – | ﹤0.01% | 292 |
|
2019
Q4 | $18K | Hold |
2,913
| – | – | ﹤0.01% | 334 |
|
2019
Q3 | $11K | Hold |
2,913
| – | – | ﹤0.01% | 357 |
|
2019
Q2 | $14K | Buy |
2,913
+1,000
| +52% | +$4.81K | ﹤0.01% | 335 |
|
2019
Q1 | $16K | Hold |
1,913
| – | – | ﹤0.01% | 317 |
|
2018
Q4 | $11K | Hold |
1,913
| – | – | ﹤0.01% | 346 |
|
2018
Q3 | $17K | Hold |
1,913
| – | – | ﹤0.01% | 314 |
|
2018
Q2 | $19K | Hold |
1,913
| – | – | ﹤0.01% | 284 |
|
2018
Q1 | $18K | Buy |
1,913
+1,000
| +110% | +$9.41K | ﹤0.01% | 295 |
|
2017
Q4 | $14K | Hold |
913
| – | – | ﹤0.01% | 314 |
|
2017
Q3 | $18K | Hold |
913
| – | – | ﹤0.01% | 307 |
|
2017
Q2 | $13K | Hold |
913
| – | – | ﹤0.01% | 345 |
|
2017
Q1 | $8K | Hold |
913
| – | – | ﹤0.01% | 364 |
|
2016
Q4 | $10K | Hold |
913
| – | – | ﹤0.01% | 311 |
|
2016
Q3 | $8K | Hold |
913
| – | – | ﹤0.01% | 340 |
|
2016
Q2 | $7K | Hold |
913
| – | – | ﹤0.01% | 373 |
|
2016
Q1 | $8K | Hold |
913
| – | – | ﹤0.01% | 344 |
|
2015
Q4 | $12K | Hold |
913
| – | – | ﹤0.01% | 304 |
|
2015
Q3 | $9K | Hold |
913
| – | – | ﹤0.01% | 327 |
|
2015
Q2 | $9K | Hold |
913
| – | – | ﹤0.01% | 337 |
|
2015
Q1 | $10K | Hold |
913
| – | – | ﹤0.01% | 321 |
|
2014
Q4 | $11K | Hold |
913
| – | – | ﹤0.01% | 298 |
|
2014
Q3 | $18K | Hold |
913
| – | – | 0.01% | 258 |
|
2014
Q2 | $18K | Buy |
+913
| New | +$18K | 0.01% | 252 |
|